Detalhe da pesquisa
1.
Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses.
J Virol
; 96(9): e0033622, 2022 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35404082
2.
Anti-EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy.
J Med Virol
; 95(5): e28793, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212266
3.
Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection.
Cell Rep Med
; 5(5): 101573, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38776874
4.
mRNA-based Vaccines Targeting the T-cell Epitope-rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti-Tumor Immunity in Mice.
Adv Sci (Weinh)
; 10(35): e2302116, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890462
5.
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV.
Cell Host Microbe
; 31(11): 1882-1897.e10, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848029
6.
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.
Signal Transduct Target Ther
; 7(1): 202, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35764603
7.
How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection.
Viruses
; 14(11)2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366470